125
Participants
Start Date
August 31, 2011
Primary Completion Date
December 31, 2012
Study Completion Date
November 30, 2013
Recombinant Human VEGF Receptor-Fc Fusion Protein
Intravitreal injection of KH902 once per month
The First Hospital of China Medical University, Shenyang
Eye & ENT Hospital of Fudan University, Shanghai
Shanghai First People's Hospital, Shanghai
Wuxi Second People's Hospital, Wuxi
Ophthalmologic Hospital of Qingdao, Qingdao
Affiliated Hospital of Wenzhou Medical College, Wenzhou
First Affiliated Hospital of Fujian Medical College, Fuzhou
Daping Hospital of the Third Military Medical University, Chongqing
People's Hospital of Wuhan University, Wuhan
Wuhan General Hospital of Guangzhou Military Command, Wuhan
Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou
University of Wisconsin, Madison
OTHER
Chengdu Kanghong Biotech Co., Ltd.
INDUSTRY